Article Details
Retrieved on: 2025-08-24 14:42:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(LLY) and emerging threats like Roche. While Novo's U.S. market share in the weight loss segment has dipped to 43% in 2025 from 69% in 2024, the ...
Article found on: www.ainvest.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here